Accelrys, Inc Company Profile

04:48 EST 11th December 2018 | BioPortfolio

The software businesses of the Oxford Molecular Group were incorporated into Accelrys Inc. on June 1, 2001.
Oxford Molecular was a leading provider of cheminformatics tools.

Founded in 1989, Oxford Molecular was listed on the London Stock Exchange in 1994. The Oxford Molecular Group grew aggressively through internal growth and the acquisition of software and experimentation-based companies. Acquired companies included Chemical Design Limited, MLR Automation, and the Genetics Computer Group (GCG®).

Oxford Molecular's primary expertise was in the area of cheminformatics, and in the consulting services associated with building enterprise informatics systems. The foundation of this offering was the RS3 discovery information management system, now integrated into the Accord family.

The Oxford Molecular software businesses were acquired by Pharmacopeia Inc. in September 2000, and combined with Pharmacopiea's other software subsidiaries in June 2001 to form Accelrys. Accelrys separated from Pharmacopeia in 2004.


10188 Telesis Court, Suite 100
San Diego
United States of America


Phone: 1 858 799 5000
Fax: 1 858 799 5100

News Articles [2 Associated News Articles listed on BioPortfolio]

Accelrys & Symyx, PTV News: Apr 06, 2010

Merger leads to US$ 335M scientific informatics software company

News Headlines, PTV News: Apr 06, 2010

A look at today's forthcoming stories: Accelrys and Symyx merge to form US$ 335M "leader in scientific informatics"; Keryx and AEterna Zentaris get fast track status for colorectal candidate, and pilo...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [5 Associated Companies listed on BioPortfolio]

Accelrys Software Inc

Accelrys provides targeted scientific software products throughout the drug discovery and development process, along with platform technologies that let you integrate best-of-breed solutions and that ...

Accelrys, Inc

The software businesses of the Oxford Molecular Group were incorporated into Accelrys Inc. on June 1, 2001.Oxford Molecular was a leading provider of cheminformatics tools. Founded in 1989, Oxford Mol...

Accelrys, Inc.

Accelrys, Inc. (NASDAQ: ACCL) is a leading provider of software for modeling, computation,simulation, and the management and mining of scientific data used by biologists, chemists,and materials scient...

Linguamatics & Accelrys

Linguamatics enables organizations to maximize the value derived from information resources through effective deployment of innovative natural language processing (NLP) based tech...


SciTegic, a wholly owned subsidiary of Accelrys, Inc., designs, develops, and markets data analysis and mining software to the scientific discovery and development industries. The company provides the...

More Information about "Accelrys, Inc" on BioPortfolio

We have published hundreds of Accelrys, Inc news stories on BioPortfolio along with dozens of Accelrys, Inc Clinical Trials and PubMed Articles about Accelrys, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Accelrys, Inc Companies in our database. You can also find out about relevant Accelrys, Inc Drugs and Medications on this site too.

Quick Search


Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Corporate Database Quicklinks

Searches Linking to this Company Record